Recent
findings: Approximately 830 women die every day worldwide as a result of
complications related to pregnancy or childbirth with obstetric hemorrhage that
remains a major cause of maternal morbidity and mortality. A systematic
analysis by the World Health Organization [WHO] on the global causes of
maternal deaths from 2003 to 2009 found that bleeding was the leading direct
cause of maternal mortality followed by hypertensive disorders and sepsis.
Overall, bleeding accounted for 27.1% of all maternal deaths worldwide. The
need to implement strategies that mitigate the impact of bleeding in this clinical
scenario is increasingly growing. Purpose of review: The purpose of this review
is to propose a management strategy based on goals established through dynamic
coagulation assessment. Summary: Effective management of obstetric hemorrhage
requires rapid recognition, rapid response and mobilization of the
multidisciplinary team. Volumetric resuscitation, hemodynamic stability, as
well as the simultaneous identification and treatment of the source of bleeding
and the resolution of coagulopathy in the shortest possible time remain the
cornerstones of the management of Postpartum Hemorrhage (PPH).
References
[1]
Committee on Practice Bulletins-Obstetrics (2017) Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists. Obstetrics & Gynecology, 130, e168-e186. https://doi.org/10.1097/aog.0000000000002351
[2]
Katz, D. and Beilin, Y. (2015) Disorders of Coagulation in Pregnancy. British Journal of Anaesthesia, 115, ii75-ii88. https://doi.org/10.1093/bja/aev374
[3]
Szecsi, P.B., Jørgensen, M., Klajnbard, A., Andersen, M.R., Colov, N.P. and Stender, S. (2010) Haemostatic Reference Intervals in Pregnancy. Thrombosis and Haemostasis, 103, 718-727. https://doi.org/10.1160/TH09-10-0704
[4]
Hiippala, S.T., Myllyla, G.J. and Vahtera, E.M. (1995) Hemostatic Factors and Replacement of Major Blood Loss with Plasma-Poor Red Cell Concentrates. Anesthesia & Analgesia, 81, 360-365. https://doi.org/10.1213/00000539-199508000-00026
[5]
Matsunaga, S., Takai, Y. and Seki, H. (2019) Fibrinogen for the Management of Critical Obstetric Hemorrhage. Journal of Obstetrics and Gynaecology Research, 45, 13-21. https://doi.org/10.1111/jog.13788
[6]
Mousa, H.A., Blum, J., Abou El Senoun, G., Shakur, H. and Alfirevic, Z. (2014) Treatment for Primary Postpartum Haemorrhage. Cochrane Database of Systematic Reviews, 2, Article No. CD003249.
https://doi.org/10.1002/14651858.CD003249.pub3
[7]
World Health Organization (2012) WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, Geneva.
[8]
Sentilhes, L., Merlot, B., Madar, H., Sztark, F., Brun, S. and Deneux-Tharaux, C. (2016) Postpartum Haemorrhage: Prevention and Treatment. Expert Review of Hematology, 9, 1043-1061. https://doi.org/10.1080/17474086.2016.1245135
[9]
Begley, C.M., Gyte, G.M., Devane, D., McGuire, W. and Weeks, A. (2011) Active versus Expectant Management for Women in the Third Stage of Labour. Cochrane Database of Systematic Reviews, 3, Article No. CD007412.
https://doi.org/10.1002/14651858.CD007412.pub3
[10]
Erez, O. (2017) Disseminated Intravascular Coagulation in Pregnancy—Clinical Phenotypes and Diagnostic Scores. Thrombosis Research, 151, S56-S60.
https://doi.org/10.1016/S0049-3848(17)30069-5
[11]
Erez, O., Mastrolia, S.A. and Thachil, J. (2015) Disseminated Intravascular Coagulation in Pregnancy: Insights in Pathophysiology, Diagnosis and Management. American Journal of Obstetrics and Gynecology, 213, 452-463.
https://doi.org/10.1016/j.ajog.2015.03.054
[12]
Cortet, M., Deneux-Tharaux, C., Dupont, C., Colin, C., Rudigoz, R.C., Bouvier-Colle, M.H., et al. (2012) Association between Fibrinogen Level and Severity of Postpartum Haemorrhage: Secondary Analysis of a Prospective Trial. British Journal of Anaesthesia, 108, 984-989. https://doi.org/10.1093/bja/aes096
[13]
Charbit, B., Mandelbrot, L., Samain, E., Baron, G., Haddaoui, B., Keita, H., et al. (2007) The Decrease of Fibrinogen is an Early Predictor of the Severity of Postpartum Hemorrhage. Journal of Thrombosis and Haemostasis, 5, 266-273.
https://doi.org/10.1111/j.1538-7836.2007.02297.x
[14]
Collins, P.W., Lilley, G., Bruynseels, D., Laurent, D.B.S., Cannings-John, R., Precious, E., et al. (2014) Fibrin-Based Clot Formation as an Early and Rapid Biomarker for Progression of Postpartum Hemorrhage: A Prospective Study. Blood, 124, 1727-1736. https://doi.org/10.1182/blood-2014-04-567891
[15]
Gando, S., Iba, T., Eguchi, Y., Ohtomo, Y., Okamoto, K., Koseki, K., et al. (2006) A Multicenter, Prospective Validation of Disseminated Intravascular Coagulation Diagnostic Criteria for Critically Ill Patients: Comparing Current Criteria. Critical Care Medicine, 34, 625-631. https://doi.org/10.1097/01.CCM.0000202209.42491.38
[16]
Taylor, J., Toh, C.H., Hoots, W.K., Wada, H. and Levi, M. (2001) Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation: On Behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation [DIC] of the International Society on Thrombosis and Haematostasis [ISTH]. Thrombosis and Haemostasis, 86, 1327-1330.
https://doi.org/10.1055/s-0037-1616068
[17]
Erez, O., Novack, L., Beer-Weisel, R., Dukler, D., Press, F., Zlotnik, A., et al. (2014) DIC Score in Pregnant Women—A Population-Based Modification of the International Society on Thrombosis and Hemostasis Score. PLoS ONE, 9, e93240.
https://doi.org/10.1371/journal.pone.0093240
[18]
Johansson, P.I., Stissing, T., Bochsen, L. and Ostrowski, S.R. (2009) Thrombelastography and Tromboelastometry in Assessing Coagulopathy in Trauma. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 17, Article No. 45.
https://doi.org/10.1186/1757-7241-17-45
[19]
Haas, T., Görlinger, K., Grassetto, A., Agostini, V., Simioni, P., Nardi, G., et al. (2014) Thromboelastometry for Guiding Bleeding Management of the Critically Ill Patient: A Systematic Review of the Literature. Minerva Anestesiologica, 80, 1320-1335.
[20]
Drumheller, B.C., Stein, D.M., Moore, L.J., Rizoli, S.B. and Cohen, M.J. (2019) Thromboelastography and Rotational Thromboelastometry for the Surgical Intensivist: A Narrative Review. Journal of Trauma and Acute Care Surgery, 86, 710-721.
https://doi.org/10.1097/TA.0000000000002206
[21]
Huissoud, C., Carrabin, N., Audibert, F., Levrat, A., Massignon, D., Berland, M., et al. (2009) Bedside Assessment of Fibrinogen Level in Postpartum Haemorrhage by Thrombelastometry. BJOG: An International Journal of Obstetrics & Gynaecology, 116, 1097-1102. https://doi.org/10.1111/j.1471-0528.2009.02187.x
[22]
De Lange, N.M., Van Rheenen-Flach, L.E., Lance, M.D., Mooyman, L., Woiski, M., Van Pampus, E.C., et al. (2014) Peri-Partum Reference Ranges for ROTEM® Thromboelastometry. British Journal of Anaesthesia, 112, 852-859.
https://doi.org/10.1093/bja/aet480
[23]
Armstrong, S., Fernando, R., Ashpole, K., Simons, R. and Columb, M. (2011) Assessment of Coagulation in the Obstetric Population Using ROTEM® Thromboelastometry. International Journal of Obstetric Anesthesia, 20, 293-298.
https://doi.org/10.1016/j.ijoa.2011.05.004
[24]
Huissoud, C., Carrabin, N., Benchaib, M., Fontaine, O., Levrat, A., Massignon, D., et al. (2009) Coagulation Assessment by Rotation Thrombelastometry in Normal Pregnancy. Journal of Thrombosis and Haemostasis, 101, 755-761.
https://doi.org/10.1160/TH08-06-0386
[25]
Duraj, L., Stasko, J., Hasko, M., Chudy, P., Sokol, J., Danko, J., et al. (2015) Monitoring of Hemostasis by Rotational Thrombelastometry during Normal Pregnancy and Postpartum. Acta Medica Martiniana, 15, 5-12.
https://doi.org/10.1515/acm-2015-0006
[26]
McNamara, H., Mallaiah, S. (2019) Managing Coagulopathy Following PPH. Best Practice and Research: Clinical Obstetrics and Gynaecology, 61, 106-120.
[27]
Padmanabhan, A., Schwartz, J. and Spitalnik, S.L. (2009) Transfusion Therapy in Postpartum Hemorrhage. Seminars in Perinatology, 33, 124-127.
[28]
Abad, M.T., Koller, T., Gual, F.A., Llop, R.N., Caro, G.A.M. and Restrepo, C.S. (2014) Goal Directed Fibrinogen Concentrate [FC] Therapy Guided by Thrombelastometry [ROTEM ®] in Massive Postpartum Hemorrhage [PPH] with Uterus atony and Severe Hypofibrinogenemia [HF]. European Journal of Anaesthesiology, 31, 103. https://doi.org/10.1097/00003643-201406001-00283
[29]
Levy, J.H., Szlam, F., Tanaka, K.A. and Sniecienski, R.M. (2012) Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding. Anesthesia & Analgesia, 114, 261-274.
https://doi.org/10.1213/ANE.0b013e31822e1853
[30]
Clifford, L. and Kor, D.J. (2015) Transfusion-Associated Circulatory Overload. In: Juffermans, N. and Walsh, T., Eds., Transfusion in the Intensive Care Unit, Springer, Cham, 171-182. https://doi.org/10.1007/978-3-319-08735-1_16
[31]
Toy, P., Popovsky, M.A., Abraham, E., Ambruso, D.R., Holness, L.G., Kopko, P.M., et al. (2005) Transfusion-Related Acute Lung Injury: Definition and Review. Critical Care Medicine, 33, 721-726. https://doi.org/10.1097/01.CCM.0000159849.94750.51
[32]
Duguid, J., O’Shaughnessy, D.F., Atterbury, C., Maggs, P.B., Murphy, M., Thomas, D., et al. (2004) Guidelines for the Use of Fresh-Frozen Plasma, Cryoprecipitate and Cryosupernatant. British Journal of Haematology, 126, 11-28.
https://doi.org/10.1111/j.1365-2141.2004.04972.x
[33]
Levy, J.H., Welsby, I. and Goodnough, L.T. (2014) Fibrinogen as a Therapeutic Target for Bleeding: A Review of Critical Levels and Replacement Therapy. Transfusion, 54, 1389-1405. https://doi.org/10.1111/trf.12431
[34]
Collins, P.W., Solomon, C., Sutor, K., Crispin, D., Hochleitner, G., Rizoli, S., et al. (2014) Theoretical Modeling of Fibrinogen Supplementation with Therapeutic Plasma, Cryoprecipitate, or Fibrinogen Concentrate. British Journal of Anaesthesia, 113, 585-595. https://doi.org/10.1093/bja/aeu086
[35]
Matsunaga, S., Takai, Y., Nakamura, E., Era, S., Ono, Y., Yamamoto, K., et al. (2017) The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with Hypofibrinogenaemia. Scientific Reports, 7, Article No. 46749.
https://doi.org/10.1038/srep46749
[36]
McNamara, H., Kenyon, C., Smith, R., Mallaiah, S. and Barclay, P. (2019) Four Years’ Experience of a ROTEM®-Guided Algorithm for Treatment of Coagulopathy in Obstetric Haemorrhage. Anaesthesia, 74, 984-991.
https://doi.org/10.1111/anae.14628
[37]
Mercier, F.J. and Bonnet, M.P. (2010) Use of Clotting Factors and Other Prohemostatic Drugs for Obstetric Hemorrhage. Current Opinion in Anaesthesiology, 23, 310-316. https://doi.org/10.1097/ACO.0b013e32833835a2
[38]
Collins, N.F., Bloor, M. and McDonnell, N.J. (2013) Hyperfibrinolysis Diagnosed by Rotational Thromboelastometry in a Case of Suspected Amniotic Fluid Embolism. International Journal of Obstetric Anesthesia, 22, 71-76.
https://doi.org/10.1016/j.ijoa.2012.09.008
[39]
Loughran, J.A., Kitchen, T.L., Sindhakar, S., Ashraf, M., Awad, M. and Kealaher, E.J. (2019) Rotational Thromboelastometry [ROTEM®]-Guided Diagnosis and Management of Amniotic Fluid Embolism. International Journal of Obstetric Anesthesia, 38, 127-130. https://doi.org/10.1016/j.ijoa.2018.09.001
[40]
Weinkove, R. and Rangarajan, S. (2008) Fibrinogen Concentrate for Acquired Hypofibrinogenaemic States. Transfusion Medicine, 18, 151-157.
https://doi.org/10.1111/j.1365-3148.2008.00854.x
[41]
McNamara, H., Mallaiah, S., Barclay, P., Chevannes, C. and Bhalla, A. (2015) Coagulopathy and Placental Abruption: Changing Management with ROTEM-Guided Fibrinogen Concentrate Therapy. International Journal of Obstetric Anesthesia, 24, 174-179. https://doi.org/10.1016/j.ijoa.2014.12.005
[42]
Crochemore, T., De Toledo Piza, F.M., Silva, E. and Corrêa, T.D. (2015) Thromboelastometry-Guided Hemostatic Therapy: An Efficacious Approach to Manage Bleeding Risk in Acute Fatty Liver of Pregnancy: A Case Report. Journal of Medical Case Reports, 9, Article No. 202. https://doi.org/10.1186/s13256-015-0690-9
